The results of a second phase study conducted by the Buffalo, NY-based Kaleida Health’s Gates Stroke Center (GSC), Gates Vascular Institute, reportedly detail the patient and fiscal benefits connected to its use of the Aquilion ONE CT system. The technology, made available through Toshiba America Medical System Inc, is designed to diagnose acute stroke.
According to a recent GSC news release, the organization reports that the benefits provided by the Aquilion ONE CT system included a $1.31 million in annualized cost savings, a reduction in patient length of stay, and improved discharge dispositions. GSC adds that the results yield from its multidisciplinary approach, enhanced education and training, and the Aquilion ONE CT technology.
GSC notes that its non-controlled study sought to quantify the benefits of the Aquilion ONE in stroke diagnosis. The study compared inpatient data sets prior to the implementation of Aquilion ONE, from July 2007 to September 2007 to data sets from July 2009 to September 2009 (the first phase of the study) and July 2010 to September 2010 (the study’s second phase). Both the first and second phases used the Auilion ONE and addressed the top three discharging ICD-9-CM codes, GSC reports.
Elad Levy, MD, FACS, FAHA, professor of neurosurgery and radiology, University at Buffalo Neurosurgery, and director of Endovascular Stroke Service, GSC, re-articulates the benefits behind the technology. “Being able to perform whole brain perfusion and digital angiography with the Aquilion ONE has enabled more efficient and accurate stroke diagnoses, while resulting in tremendous patient and cost savings benefits,” Levy says. Levy adds that the study also exhibits year-over-year improvements as the facility continues to pinpoint additional ways to maximize the technology.
Source: Toshiba Medical Systems Corporation